The interplay between Src and integrins in normal and tumor biology
The DOI matches its Crossref record; 222 of the 222 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The phosphatidylinositol 3-Kinase–AKT pathway in human cancer
Vivanco, I., & Sawyers, C. L. (2002) · Nature Reviews Cancer · doi:10.1038/nrc839 · Cited by 6,056
Ridley, A. J., & Hall, A. (1992) · Cell · doi:10.1016/0092-8674(92)90163-7 · Cited by 4,468
Cellular Motility Driven by Assembly and Disassembly of Actin Filaments
Pollard, T. D., & Borisy, G. G. (2003) · Cell · doi:10.1016/s0092-8674(03)00120-x · Cited by 4,195
CELLULAR FUNCTIONS REGULATED BY SRC FAMILY KINASES
Thomas, S. M., & Brugge, J. S. (1997) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.13.1.513 · Cited by 2,498
Integrin αvβ3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels
Brooks, P. C., Montgomery, A. M. P., Rosenfeld, M., Reisfeld, R. A., Hu, T., Klier, G., & Cheresh, D. A. (1994) · Cell · doi:10.1016/0092-8674(94)90007-8 · Cited by 2,262 · cited 1×
“Integrins avb3 and a5b1 have been found to be highly upregulated on angiogenic vessels (Brooks et al., 1994; Kim et al., 2000).”
BackgroundTargeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice
Soriano, P., Montgomery, C., Geske, R., & Bradley, A. (1991) · Cell · doi:10.1016/0092-8674(91)90499-o · Cited by 2,016
Reduced cell motility and enhanced focal adhesion contact formation in cells from FAK-deficient mice
llić, D., Furuta, Y., Kanazawa, S., Takeda, N., Sobue, K., Nakatsuji, N., Nomura, S., Fujimoto, J., Okada, M., Yamamoto, T., et al. (1995) · Nature · doi:10.1038/377539a0 · Cited by 1,830
Role of integrins in cell invasion and migration
Hood, J. D., & Cheresh, D. A. (2002) · Nature Reviews Cancer · doi:10.1038/nrc727 · Cited by 1,777
Integrin-mediated signal transduction linked to Ras pathway by GRB2 binding to focal adhesion kinase
Schlaepfer, D. D., Hanks, S. K., Hunter, T., & Geer, P. V. D. (1994) · Nature · doi:10.1038/372786a0 · Cited by 1,595 · cited 1×
“The binding of Src with FAK at tyrosine 397 leads to phosphorylation of the remaining sites of tyrosine phosphorylation in FAK, namely Y407, 576, 577, 861 and 925 (Schaller et al., 1994; Schlaepfer et al., 1994; Calalb et al., 1995, 1996) (Figures 2 and 3).”
BackgroundMinden, A., Lin, A., Claret, F.-X., Abo, A., & Karin, M. (1995) · Cell · doi:10.1016/s0092-8674(05)80019-4 · Cited by 1,478
Cited by
Tumor metastasis: mechanistic insights and clinical challenges
Steeg, P. S. (2006) · Nature Medicine · doi:10.1038/nm1469 · Cited by 2,134
Integrin-regulated FAK–Src signaling in normal and cancer cells
Mitra, S. K., & Schlaepfer, D. D. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.08.011 · Cited by 1,590
Physiology of cell volume regulation in vertebrates
Hoffmann, E. K., Lambert, I. H., & Pedersen, S. F. (2009) · Physiological Reviews · doi:10.1152/physrev.00037.2007 · Cited by 1,441
The signaling mechanism of ROS in tumor progression
Wu, W.-S. (2007) · Cancer and Metastasis Reviews · doi:10.1007/s10555-006-9037-8 · Cited by 752
Provenzano, P. P., Inman, D. R., Eliceiri, K. W., & Keely, P. J. (2009) · Oncogene · doi:10.1038/onc.2009.299 · Cited by 675
Spatial regulation of β-actin translation by Src-dependent phosphorylation of ZBP1
Hüttelmaier, S., Zenklusen, D., Lederer, M., Dictenberg, J., Lorenz, M., Meng, X., Bassell, G. J., Condeelis, J., & Singer, R. H. (2005) · Nature · doi:10.1038/nature04115 · Cited by 647
Spatial organization of the extracellular matrix regulates cell–cell junction positioning
Tseng, Q., Duchemin-Pelletier, E., Deshiere, A., Balland, M., Guillou, H., Filhol, O., & Théry, M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1106377109 · Cited by 594
Banerjee, M., Cui, X., Li, Z., Yu, H., Cai, L., Jia, X., He, D., Wang, C., Gao, T., & Xie, Z. (2018) · Scientific Reports · doi:10.1038/s41598-018-29995-2 · Cited by 506
Provenzano, P. P., & Keely, P. J. (2011) · Journal of Cell Science · doi:10.1242/jcs.067009 · Cited by 494
Cellular Characterization of a Novel Focal Adhesion Kinase Inhibitor
Slack-Davis, J. K., Martin, K. H., Tilghman, R. W., Iwanicki, M., Ung, E. J., Autry, C., Luzzio, M. J., Cooper, B., Kath, J. C., Roberts, W. G., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606695200 · Cited by 483
Src signaling in cancer invasion
Guarino, M. (2010) · Journal of Cellular Physiology · doi:10.1002/jcp.22011 · Cited by 426
FAK signaling in human cancer as a target for therapeutics
Lee, B. Y., Timpson, P., Horvath, L. G., & Daly, R. J. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.10.001 · Cited by 425
Ginsberg, M. H., Partridge, A., & Shattil, S. J. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.010 · Cited by 415
Finn, R. S., Dering, J., Ginther, C., Wilson, C. A., Glaspy, P., Tchekmedyian, N., & Slamon, D. J. (2007) · Breast Cancer Research and Treatment · doi:10.1007/s10549-006-9463-x · Cited by 409
Antitumor Activity and Pharmacology of a Selective Focal Adhesion Kinase Inhibitor, PF-562,271
Roberts, W. G., Ung, E., Whalen, P., Cooper, B., Hulford, C., Autry, C., Richter, D., Emerson, E., Lin, J., Kath, J., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-5155 · Cited by 378
Action of the Src Family Kinase Inhibitor, Dasatinib (BMS-354825), on Human Prostate Cancer Cells
Nam, S., Kim, D., Cheng, J. Q., Zhang, S., Lee, J.-H., Buettner, R., Mirosevich, J., Lee, F. Y., & Jove, R. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1731 · Cited by 377
Integrins and cadherins join forces to form adhesive networks
Weber, G. F., Bjerke, M. A., & DeSimone, D. W. (2011) · Journal of Cell Science · doi:10.1242/jcs.064618 · Cited by 345
Src family kinases: Regulation of their activities, levels and identification of new pathways
Ingley, E. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.08.012 · Cited by 335
Targeting Src family kinases in anti-cancer therapies: turning promise into triumph
Zhang, S., & Yu, D. (2012) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2011.11.002 · Cited by 319
Balatti, V., Nigita, G., Veneziano, D., Drusco, A., Stein, G. S., Messier, T. L., Farina, N. H., Lian, J. B., Tomasello, L., Liu, C.-G., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1706908114 · Cited by 283
CZH proteins: a new family of Rho-GEFs
Meller, N., Merlot, S., & Guda, C. (2005) · Journal of Cell Science · doi:10.1242/jcs.02671 · Cited by 277
Koenig, A., Mueller, C., Hasel, C., Adler, G., & Menke, A. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2804 · Cited by 277
Clines, G. A., & Guise, T. A. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.00543 · Cited by 253
Preclinical anticancer activity of the potent, oral Src inhibitor AZD0530
Green, T. P., Fennell, M., Whittaker, R., Curwen, J., Jacobs, V., Allen, J., Logie, A., Hargreaves, J., Hickinson, D. M., Wilkinson, R. W., et al. (2009) · Molecular Oncology · doi:10.1016/j.molonc.2009.01.002 · Cited by 238
Destaing, O., Sanjay, A., Itzstein, C., Horne, W. C., Toomre, D., De Camilli, P., & Baron, R. (2008) · Molecular Biology of the Cell · doi:10.1091/mbc.e07-03-0227 · Cited by 217
“The nonreceptor tyrosine kinase Src plays multiple roles in integrin signaling, in the regulation of the cell cytoskeleton and in cell migration (Sanjay et al., 2001; Frame, 2004; Playford and Schaller, 2004; Alper and Bowden, 2005).”
BackgroundSRC: A Century of Science Brought to the Clinic
Aleshin, A., & Finn, R. S. (2010) · Neoplasia · doi:10.1593/neo.10328 · Cited by 211
Mitra, D., Brumlik, M. J., Okamgba, S. U., Zhu, Y., Duplessis, T. T., Parvani, J. G., Lesko, S. M., Brogi, E., & Jones, F. E. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0295 · Cited by 204
“Src kinase is known to facilitate cell motility and invasion, in part, through activation of FAK (36).”
BackgroundInfluentialBrown, M. C., Cary, L. A., Jamieson, J. S., Cooper, J. A., & Turner, C. E. (2005) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-02-0131 · Cited by 197
“Src function is closely linked to that of FAK (Playford and Schaller, 2004).”
BackgroundLu, C., Bonome, T., Li, Y., Kamat, A. A., Han, L. Y., Schmandt, R., Coleman, R. L., Gershenson, D. M., Jaffe, R. B., Birrer, M. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3700 · Cited by 182
“It is well known that Src family tyrosine kinases play an essential role in the signaling of integrin-mediated biological processes such as cell proliferation, differentiation, actin organization, and cell migration (37).”
BackgroundmiR-34a Silences c-SRC to Attenuate Tumor Growth in Triple-Negative Breast Cancer
Adams, B. D., Wali, V. B., Cheng, C. J., Inukai, S., Booth, C. J., Agarwal, S., Rimm, D. L., Győrffy, B., Santarpia, L., Pusztai, L., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2321 · Cited by 174
“5-fold greater rates of invasion than Empty-GFP cells, as would be expected given the promigratory phenotypes conferred by c-SRC through activation of FAK, RhoA, and PAK signaling (36).”
BackgroundThe EphA4 receptor regulates dendritic spine remodeling by affecting β1-integrin signaling pathways
Bourgin, C., Murai, K. K., Richter, M., & Pasquale, E. B. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200610139 · Cited by 136
The Lipid Raft-Anchored Adaptor Protein Cbp Controls the Oncogenic Potential of c-Src
Oneyama, C., Hikita, T., Enya, K., Dobenecker, M.-W., Saito, K., Nada, S., Tarakhovsky, A., & Okada, M. (2008) · Molecular Cell · doi:10.1016/j.molcel.2008.03.026 · Cited by 116
Combination of MEK and SRC inhibition suppresses melanoma cell growth and invasion
Ferguson, J., Arozarena, I., Ehrhardt, M., & Wellbrock, C. (2013) · Oncogene · doi:10.1038/onc.2012.25 · Cited by 68
“Importantly, because integrin-mediated cell adhesion is tightly regulated by SRC kinases (14, 15), the ‘mesenchymal’ mode of invasion is extremely sensitive to SRC kinase inhibitors (16).”
BackgroundSpatiotemporal dynamics of GEF-H1 activation controlled by microtubule- and Src-mediated pathways
Azoitei, M. L., Noh, J., Marston, D. J., Roudot, P., Marshall, C. B., Daugird, T. A., Lisanza, S. L., Sandí, M.-J., Ikura, M., Sondek, J., et al. (2019) · Journal of Cell Biology · doi:10.1083/jcb.201812073 · Cited by 61
“Given that Src is active at the cell edge and that it plays a major role in controlling edge morphodynamics (Playford and Schaller, 2004; Chu et al., 2014), we decided to investigate whether Src regulates GEF-H1 to control protrusions.”
BackgroundZheng, X., Resnick, R. J., & Shalloway, D. (2008) · International Journal of Cancer · doi:10.1002/ijc.23321 · Cited by 60
“Integrin-mediated pathways may also be involved: some experiments suggest that Src suppresses apoptosis in some cancer cell types via its role in integrin-mediated attachment and signaling, probably via Akt-mediated pathways.(43) In particular, inhibiting Src increases the susceptibility of HT-29 colon cancer cells to…”
BackgroundQu, H., Tu, Y., Guan, J.-L., Xiao, G., & Wu, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.580811 · Cited by 43
“A large body of evidence suggests that tyrosine phosphorylation of paxillin involves not only FAK but also Src (16, 25, 30).”
BackgroundChen, P.-H., Peng, C.-Y., Pai, H.-C., Teng, C.-M., Chen, C.-C., & Yang, C.-R. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.06.004 · Cited by 28
“Focal adhesion kinase (FAK), one such substrate of Src, plays an important role in integrin signaling and is highly expressed in many tumor cells [16].”
Background
Metadata
- Authors
- Playford, M. P., & Schaller, M. D.
- Venue
- Oncogene
- Published
- 2004-10-18
- Volume
- 23
- Issue
- 48
- Pages
- 7928-7946
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2059552745
- Cited by
- 523
- References
- 222
- FWCI
- 17.97
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.